Explorer

AstraZeneca Begins Trial For Booster Vaccine Against COVID-19 Beta Variant

If the experts of the country are to be believed, despite Britain carrying out a successful vaccine rollout program, uncertainty about how long the protection of the vaccine will last in a person’s body still remains. 

AstraZeneca began trials for modified booster vaccine against Beta variant of COVID-19. On Sunday, AstraZeneca and the University of Oxford started fresh trials to test an improved vaccine against the Beta form, which was first discovered in South Africa. 

Around 2,250 people from the United Kingdom, South Africa, Brazil, and Poland will take part in the 'booster' vaccine trial. The individuals involved in the trial will include those who have received two doses of the original Oxford-AstraZeneca vaccination or a Pfizer mRNA vaccine, along with those who have not received the vaccine at all. 

"Testing booster doses of existing vaccines and a new variant, vaccines are important to ensure we are best prepared to stay ahead of the pandemic coronavirus, should their use be needed," said Andrew Pollard, chief investigator, and director of the Oxford Vaccine Group at the University of Oxford. 

If the experts of the country are to be believed, despite Britain carrying out a successful vaccine rollout program, uncertainty about how long the protection of the vaccine will last in a person’s body still remains. 

According to Maheshi Ramasamy, Principal Investigator at the Oxford Vaccine Group, "this study will provide vital evidence on whether further doses including 'tweaks' against new virus variants may be needed in the future". 

The first results of these trials are expected to be released later this year. 

The existing vaccines are thought to be less efficacious against the Beta version, however, the Delta variant which developed in India, is the reason for the most concern right now. 

Despite the fact that the primary vaccines are considered to be highly efficient at avoiding serious illness, the Delta variant's infectious characteristics have resulted in an increase in cases in some countries, including the United Kingdom. The UK saw a rise of 35.204 cases in the last week taking the total case tally to 111,157. 

Check out below Health Tools-
Calculate Your Body Mass Index ( BMI )

Calculate The Age Through Age Calculator

View More
Advertisement
Advertisement
25°C
New Delhi
Rain: 100mm
Humidity: 97%
Wind: WNW 47km/h
See Today's Weather
powered by
Accu Weather
Advertisement

Top Headlines

Delhi Water Crisis: DJB Office Vandalised, People Queue Up For Water As AAP And BJP Trade Blame — Updates
Delhi: DJB Office Vandalised, People Queue Up For Water As AAP And BJP Trade Blame — Updates
Opinion | Drones And Counter Drones — New Challenge For Indian Armed Forces
Drones And Counter Drones — New Challenge For Indian Armed Forces
'Will Have More To Say When...': Here's What Justin Trudeau Said On Inviting PM Modi To G7 Next Year
'Will Have More To Say When...': Here's What Justin Trudeau Said On Inviting PM Modi To G7 Next Year
Amit Shah Chairs Meeting To Review Security Situation In J&K. NSA Doval, LG Manoj Sinha Attend
Amit Shah Chairs Meeting To Review Security Situation In J&K. NSA Doval, LG Manoj Sinha Attend
Advertisement
metaverse

Videos

G7 Summit: PM Modi and Meloni's 'Hello from Melody' video goes viral | ABP LIVEG7 Summit: PM Modi & Italian Counterpart Meloni's selfie viral, 'Hello from the Melody Team' trends heavilyG7 Summit: Modi to participate in G7 summit in Italy, Discussion likely on approving 2 resolutions against ChinaDelhi Water Crisis: People troubled by water shortages vent their anger by vandalizing Water Board offices

Photo Gallery

Embed widget